MyAverix Finance
WAR · Healthcare
SCS (SCS)
Biotechnology & Medical Research
SCS (SCS) is listed on WAR in the Healthcare sector. Industry: Biotechnology & Medical Research. As of 2026-05-24, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for SCS
SCS (SCS) — FAQ
What is SCS's P/E ratio?
The price-to-earnings (P/E) ratio for SCS (SCS) is 25.00 (data as of 2026-05-24).
Does SCS pay a dividend?
Dividend yield is not available in the current snapshot for SCS (SCS). Check the MyAverix Finance app for the latest dividend data.
What sector is SCS in?
SCS (SCS) is classified in the Healthcare sector (Biotechnology & Medical Research industry).
What exchange is SCS listed on?
SCS is listed on WAR.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.